|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Endocrine Section and Research Service, G.V. (Sonny) Montgomery VA Medical Center, Jackson, MS, USA; Division of Endocrinology, The University of Mississippi Medical Center, Jackson, MS, USA; Department of Medicine, University of Missouri-Columbia, Columbia, MO, USA
2 Department of Veterinary Biomedical Sciences, University of Missouri-Columbia, Columbia, MO, USA
3 Department of Medicine, University of Missouri-Columbia, Columbia, MO, USA
4 Division of Endocrinology, The University of Mississippi Medical Center, Jackson, MS, USA
5 Department of Pathology, The University of Mississippi Medical Center, Jackson, MS, USA
* To whom correspondence should be addressed. E-mail: elise.gomezsanchez{at}med.va.gov.
The 11-beta-hydroxysteroid dehydrogenase type1 (11
HSD1) is an NADP+-dependent oxido-reductase, usually reductase, of major glucocorticoids. The NAD+-dependent 11
HSD2 is an oxidase that inactivates cortisol and corticosterone, conferring extrinsic specificity of the mineralocorticoid receptor for aldosterone. We reported that addition of a reducing agent to renal homogenates results in the monomerization of 11
HSD2 dimers and a significant increase in NAD+-dependent corticosterone conversion. Estrogenic effects on expression, dimerization, and activity of the kidney 11
HSD1 and 2 enzymes are described herein. Renal 11
HSD1 mRNA and protein expression were decreased to very low levels by estradiol (E2) treatment of both intact and castrated male rats; testosterone had no effect. NADP+-dependent enzymatic activity of renal homogenates from E2-treated rats measured under non-reducing conditions was less than that of homogenates from intact animals. Addition of 10mM dithiothreitol to aliquots from these same homogenates abrogated the difference in NADP+-dependent activity between E2-treated and control rats. In contrast, 11
HSD2 mRNA and protein expressions were significantly increased by E2-treatment. There was a marked increase in the number of juxtamedullary proximal tubules stained by the antibody against 11
HSD2 after the administration of E2. Notwithstanding, neither the total corticosterone and 11-dehydrocorticosterone excreted in the urine, nor their ratio, differed between E2 or vehicle-treated rats. NAD+-dependent enzymatic activity in the absence or presence of a reducing agent demonstrated that the increase in 11
HSD2 protein was not associated with an increase in in vitro activity unless the dimers were reduced to monomers.
This article has been cited by other articles:
![]() |
E. P. Gomez-Sanchez, M. T. Gomez-Sanchez, A. F. de Rodriguez, D. G. Romero, M. P. Warden, M. W. Plonczynski, and C. E. Gomez-Sanchez Immunohistochemical Demonstration of the Mineralocorticoid Receptor, 11{beta}-Hydroxysteroid Dehydrogenase-1 and -2, and Hexose-6-phosphate Dehydrogenase in Rat Ovary J. Histochem. Cytochem., July 1, 2009; 57(7): 633 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Tomlinson, J. Finney, C. Gay, B. A. Hughes, S. V. Hughes, and P. M. Stewart Impaired Glucose Tolerance and Insulin Resistance Are Associated With Increased Adipose 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression and Elevated Hepatic 5{alpha}-Reductase Activity Diabetes, October 1, 2008; 57(10): 2652 - 2660. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Komiyama, R. Nishimura, H.-Y. Lee, R. Sakumoto, M. Tetsuka, T. J. Acosta, D. J. Skarzynski, and K. Okuda Cortisol Is a Suppressor of Apoptosis in Bovine Corpus Luteum Biol Reprod, May 1, 2008; 78(5): 888 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Usa, R. J. Singh, B. C. Netzel, Y. Liu, H. Raff, and M. Liang Renal interstitial corticosterone and 11-dehydrocorticosterone in conscious rats Am J Physiol Renal Physiol, July 1, 2007; 293(1): F186 - F192. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Thiesson, B. L. Jensen, C. Bistrup, P. D. Ottosen, A. D. McNeilly, R. Andrew, J. Seckl, and O. Skott Renal sodium retention in cirrhotic rats depends on glucocorticoid-mediated activation of mineralocorticoid receptor due to decreased renal 11beta-HSD-2 activity Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R625 - R636. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |